newsfilter
← Latest News
ACCESS Newswire·

Cytocom and Cleveland BioLabs Announce Definitive Merger Agreement

Merger to create a single public company focused on the development and commercialization of immunotherapies for oncology, infectious disease, inflammation and auto-immune mediated conditions